Deal Corner
April 30, 2019
Series B Investment in Mfine - A heath-tech startup

DEAL BRIEF

SBI (through its investment vehicles in Japan and Singapore), Beenext, along with other investors led the Series B investment of approx. USD 17 million into NovoCura Tech Health Services Private Limited (doing business as ‘mfine’), a health-tech startup based out of Bengaluru, India. Mfine was founded in 2017 by Ashutosh Lawania (co-founder of Myntra) and Prasad Kompalli (former chief business officer of Myntra).

SBI is an internet-based financial conglomerate from Japan and Beenext is a leading venture capital firm from Singapore. Press coverage, relating to the transaction, is available at the Hindu Business Line and Livemint.

OUR ROLE

We, at Nishith Desai Associates,acted as legal counsels to SBI and Beenext. We advised them on the legal, regulatory and strategic aspects of the transaction.

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.

Deal Corner

April 30, 2019

Series B Investment in Mfine - A heath-tech startup

DEAL BRIEF

SBI (through its investment vehicles in Japan and Singapore), Beenext, along with other investors led the Series B investment of approx. USD 17 million into NovoCura Tech Health Services Private Limited (doing business as ‘mfine’), a health-tech startup based out of Bengaluru, India. Mfine was founded in 2017 by Ashutosh Lawania (co-founder of Myntra) and Prasad Kompalli (former chief business officer of Myntra).

SBI is an internet-based financial conglomerate from Japan and Beenext is a leading venture capital firm from Singapore. Press coverage, relating to the transaction, is available at the Hindu Business Line and Livemint.

OUR ROLE

We, at Nishith Desai Associates,acted as legal counsels to SBI and Beenext. We advised them on the legal, regulatory and strategic aspects of the transaction.

Disclaimer

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.